Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.27
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Qualis Innovations, Inc. focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. The company is headquartered in Chadds Ford, Pennsylvania.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Data is available to registered users only
Buy
Sell